NEU 1.75% $14.31 neuren pharmaceuticals limited

Ann: Pause in Trading, page-24

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 24 Posts.
    A trading halt can last a few days, pauses usually a lot quicker.
    The Cupler research report is available on their website.

    Culver claim Acadia have misrepresented Daybues safety profile. They've used pretty colourful terminology / language 'horror' stories.
    Interesting that then then still see annualised sales of circa $230m annually out to 2030.
    So they need to decide, is their call a binary one? It either works or it doesn't.

    Many of the side effects they claim were included in the NEU release, so not a lot of new news there.
    It's not a particularly well balanced research report in my view, but as a shareholder one might claim I'm not being as objective as I might otherwise be.

    I expect a key barometer going forward will be whether insurance companies continue to reimburse and any definitive feedback on that front.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.